ZESTRIL

Swiss trademark · 348526 · Word mark · In force

Register entry

Registration number
348526
Application number
01163/1986
Status
In force
Type
Word mark
Filed
Feb 26, 1986
Registered
Oct 2, 1986
Published
Nov 1, 1986
Protected until
Feb 26, 2036
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Prophylaxe und/oder Behandlung von Hypertonie und anderen Störungen und Erkrankungen des kardiovasculären Systems.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 24, 2026

    Renewed

    Expiry date
    26.02.2026 → 26.02.2036

    Published in Swissreg on 24.02.2026

  2. Nov 17, 2021

    Agent removed

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel (removed)

    Published in Swissreg on 17.11.2021

  3. Nov 17, 2021

    Transferred

    Owner
    AstraZeneca UK Limited, 15 Stanhope Gate, London W1Y 6LN, United Kingdom → ATNAHS PHARMA UK LIMITED, Suite 1, 3rd Floor 11-12 St. James's Square, London SW1Y 4LB, United Kingdom
    Representative
    Swissberg AG, Seefeldstrasse 224, Postfach, 8034 Zürich

    Published in Swissreg on 17.11.2021

  4. Dec 30, 2015

    Renewed

    Published in Swissreg on 30.12.2015

  5. Jul 8, 2014

    Agent’s address changed

    Representative
    BOHEST AG, Postfach 160, 4003 Basel → BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 08.07.2014

  6. May 5, 2008

    Agent’s address changed

    Representative
    A. Braun Braun Héritier Eschmann AG, Patentanwälte VSP, Holbeinstrasse 36-38, Postfach 160, 4003 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in the SOGC no. 85 of 05.05.2008

  7. Apr 3, 2006

    Renewed

    Published in the SOGC no. 65 of 03.04.2006

  8. Jul 22, 2002

    Transferred

    Owner
    Zeneca Limited, Imperial Chemical House, 9, Millbank, GB- London SW1P 3JF, United Kingdom → AstraZeneca UK Limited, 15 Stanhope Gate, London W1Y 6LN, United Kingdom
    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → A. Braun Braun Héritier Eschmann AG, Patentanwälte VSP, Holbeinstrasse 36-38, Postfach 160, 4003 Basel
    License holder
    ICI-Pharma, Landenbergstrasse 34, Postfach, 6002 Luzern (removed)

    Published in the SOGC no. 139 of 22.07.2002

4 earlier entries
  1. Mar 8, 1994

    Transferred

    Owner
    Imperial Chemical Industries PLC, Imperial Chemical House, Millbank, London S.W.1 (GB), United Kingdom → Zeneca Limited, Imperial Chemical House, 9, Millbank, GB- London SW1P 3JF, United Kingdom

    Published in the SOGC no. 47 of 08.03.1994

  2. Dec 22, 1993

    Licensee entered

    License holder
    ICI-Pharma, Landenbergstrasse 34, Postfach, 6002 Luzern

    Published in the SOGC no. 249 of 22.12.1993

  3. May 6, 1987

    Partly deleted

    LGS
    Pharmazeutische Präparate und Substanzen. → Pharmazeutische Präparate zur Prophylaxe und/oder Behandlung von Hypertonie und anderen Störungen und Erkrankungen des kardiovasculären Systems.
    International classification
    5 → 5

    Published in the SOGC no. 102 of 06.05.1987

  4. Nov 1, 1986

    Registered

    Published in the SOGC no. 255 of 01.11.1986

Parties

Holder

Atnahs Pharma UK Limited

ATNAHS PHARMA UK LIMITED

Suite 1, 3rd Floor 11-12 St. James's Square, London SW1Y 4LB, GB

Agent

Swissberg AG

Seefeldstrasse 224 Postfach, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.